Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

• Carla L. Alves,
• Sidse Ehmsen,
• Mikkel G. Terp,
• Neil Portman,
• Martina Tuttolomondo,
• Odd L. Gammelgaard,
• Monique F. Hundebøl,
• Kamila Kaminska,
• Lene E. Johansen,
• Martin Bak,
• Gabriella Honeth,
• Ana Bosch,
• Elgene Lim,
• Henrik J. Ditzel

Affiliations

Carla L. Alves

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Sidse Ehmsen

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Mikkel G. Terp

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Neil Portman

Garvan Institute of Medical Research

Martina Tuttolomondo

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Odd L. Gammelgaard

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Monique F. Hundebøl

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Kamila Kaminska

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University

Lene E. Johansen

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark

Martin Bak

Department of Pathology, Sydvestjysk Sygehus

Gabriella Honeth

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University

Ana Bosch

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University

Elgene Lim

Garvan Institute of Medical Research

Henrik J. Ditzel

Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark